Literature DB >> 29030768

Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD).

Diego Franciotta1, Matteo Gastaldi2, Arianna Sala3, Francesca Andreetta4, Elena Rinaldi4, Maddalena Ruggieri5, Rosaria Leante5, Gianna Costa6, Tiziana Biagioli7, Luca Massacesi8, Elena Bazzigaluppi9, Raffaella Fazio9, Sara Mariotto10, Sergio Ferrari10, Elisabetta Galloni11, Francesco Perini11, Elisabetta Zardini2, Luigi Zuliani12, Marco Zoccarato13, Bruno Giometto13, Antonio Bertolotto3.   

Abstract

This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.

Entities:  

Keywords:  Anti-aquaporin-4 antibodies; Anti-myelin oligodendrocyte glycoprotein antibodies; Cell-based assay; Laboratory diagnostics; Neurological autoimmune diseases

Mesh：

Substances：

Year:  2017        PMID： 29030768     DOI： 10.1007/s10072-017-3027-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  31 in total

Review 1.  Anti-endothelial cell antibodies (AECA) in patients with systemic vasculitis: our research using proteomics.

Authors:  Rie Karasawa; Kazuo Yudoh; Shoichi Ozaki; Tomohiro Kato
Journal:  Expert Opin Biol Ther       Date:  2011-01       Impact factor: 4.388

2.  Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

Authors:  P J Waters; A McKeon; M I Leite; S Rajasekharan; V A Lennon; A Villalobos; J Palace; J N Mandrekar; A Vincent; A Bar-Or; S J Pittock
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

Review 3.  Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Brain Pathol       Date:  2013-11       Impact factor: 6.508

4.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Authors:  Joanna Kitley; Patrick Waters; Mark Woodhall; M Isabel Leite; Andrew Murchison; Jithin George; Wilhelm Küker; Saleel Chandratre; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

5.  Aquaporin-4 autoantibodies in a paraneoplastic context.

Authors:  Sean J Pittock; Vanda A Lennon
Journal:  Arch Neurol       Date:  2008-05

6.  Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Authors:  Ingo Kleiter; Anna Gahlen; Nadja Borisow; Katrin Fischer; Klaus-Dieter Wernecke; Brigitte Wegner; Kerstin Hellwig; Florence Pache; Klemens Ruprecht; Joachim Havla; Markus Krumbholz; Tania Kümpfel; Orhan Aktas; Hans-Peter Hartung; Marius Ringelstein; Christian Geis; Christoph Kleinschnitz; Achim Berthele; Bernhard Hemmer; Klemens Angstwurm; Jan-Patrick Stellmann; Simon Schuster; Martin Stangel; Florian Lauda; Hayrettin Tumani; Christoph Mayer; Lena Zeltner; Ulf Ziemann; Ralf Linker; Matthias Schwab; Martin Marziniak; Florian Then Bergh; Ulrich Hofstadt-van Oy; Oliver Neuhaus; Alexander Winkelmann; Wael Marouf; Jürgen Faiss; Brigitte Wildemann; Friedemann Paul; Sven Jarius; Corinna Trebst
Journal:  Ann Neurol       Date:  2015-11-26       Impact factor: 10.422

7.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

8.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

9.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

10.  Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity.

Authors:  Francesco Pisani; Angelo Sparaneo; Carla Tortorella; Maddalena Ruggieri; Maria Trojano; Maria Grazia Mola; Grazia Paola Nicchia; Antonio Frigeri; Maria Svelto
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240
View more
  6 in total

1.  A new M23-based ELISA assay for anti-aquaporin 4 autoantibodies: diagnostic accuracy and clinical correlation.

Authors:  Marilina Tampoia; Letizia Abbracciavento; Giuseppina Barberio; Martina Fabris; Nicola Bizzaro
Journal:  Auto Immun Highlights       Date:  2019-06-19

2.  Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Silvia Scaranzin; Antonio Uccelli; Francesca Andreetta; Fulvio Baggi; Diego Franciotta
Journal:  Front Neurol       Date:  2020-01-14       Impact factor: 4.003

3.  A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.

Authors:  Ariana de Souza Moraes; Doralina Guimarães Brum; Jéssica Cristiane Magalhães Ierich; Akemi Martins Higa; Amanda Stefanie Jabur Assis; Celina Massumi Miyazaki; Flávio Makoto Shimizu; Luís Antonio Peroni; M Teresa Machini; Amilton Antunes Barreira; Marystela Ferreira; Osvaldo N Oliveira; Fabio Lima Leite
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

4.  Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients.

Authors:  Ping Chen; Mingmei Wu; Ning Wang; Feng Xia; Fang Du; Zhirong Liu; Jinchun Wang; Jingyi Jin; Boquan Jin; Gang Zhao; Lihua Chen; Jing Yi; Liang Fang
Journal:  Brain Behav       Date:  2022-05-19       Impact factor: 3.405

5.  Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders.

Authors:  Andrea Marcinnò; Fabiana Marnetto; Paola Valentino; Serena Martire; Alessia Balbo; Aurora Drago; Maria Leto; Marco Capobianco; Giancarlo Panzica; Antonio Bertolotto
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-09-13

6.  Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines.

Authors:  Hye Lim Lee; Su-Hyun Kim; Jin Myoung Seok; Byung Jo Kim; Ho Jin Kim; Byoung Joon Kim
Journal:  J Clin Neurol       Date:  2022-03       Impact factor: 3.077
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.